Evommune EVMN Common stock, shares authorized (in shares)
Common stock, shares authorized (in shares) at other companies
Other financials
Where this comes from
Reported directly by Evommune in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Evommune 's common stock, shares authorized (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Evommune 's common stock, shares authorized (in shares)?
- Evommune (EVMN) reported common stock, shares authorized (in shares) of $220M in Q1 2026.
- What is the long-term trend for Evommune 's common stock, shares authorized (in shares)?
- Over 2 years (2020 to 2025), Evommune 's common stock, shares authorized (in shares) has grown at a 48.3% compound annual growth rate (CAGR), from $100M to $220M.